Investors pump $37.5M into Alimera Sciences

02/19/2014 | (Boston)

Georgia-based Alimera Sciences has obtained $37.5 million in financing from 21 undisclosed backers, which would go toward the company's general corporate functions. After some regulatory setbacks, the company's Iluvien drug-device combination was allowed last year to head straight to final FDA review.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA